prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - M. Pathologic Interpretation: A. SENTINEL NODE #1 COUNT. - METASTATIC CARCINOMA TO ONE LYMPH NODE (1/1). B. SENTINEL NODE #2 COUNT. - METASTATIC CARCINOMA TO ONE LYMPH NODE (1/1). C. RIGHT TOTAL MASTECTOMY: - INFILTRATING DUCTAL CARCINOMA, NOTTINGHAM GRADE 2 (3+2+2=7), 1.6 CM IN GREATEST. DIMENSION. - RESECTION MARGINS ARE FREE OF TUMOR, CLOSEST MARGIN AT 2.0 CM (DEEP). - PREDICTIVE MARKERS PERFORMED ON PREVIOUS BIOPSY: ER AND PR POSITIVE BY. IMMUNOHISTOCHEMISTRY AND HER2 AMPLIFIED BY FISH. - NO MALIGNANCY SEEN IN FIVE LYMPH NODES (0/5). - PLEASE SEE TUMOR SUMMARY. AJCC: pT1c, pN1a, pMn/a. Tumor Summary: Specimen: - Total breast (including nipple and skin). Procedure: - Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph node(s). - Axillary dissection (partial or complete dissection). Specimen Integrity: - Single intact specimen (margins can be evaluated). Specimen Laterality: - Right. Tumor Site: Invasive Carcinoma. - Central. Tumor Size: Size of Largest Invasive Carcinoma. - Greatest dimension of largest focus of invasion over 0.1 cm: 1.6 cm. Tumor Focality: - Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Invasive carcinoma does not invade into the dermis or epidermis. - Nipple: DCIS does not involve the nipple epidermis. Skeletal muscle: No skeletal muscle present. Ductal Carcinoma In (DCIS): DCIS is present. Size (Extent) of DCIS: Estimated size (extent) of DCIS (greatest dimension using gross and microscopic evaluation) is at least: 0.5 cm. Number of blocks with DCIS: 5. Number of blocks examined: 10. - Architectural Patterns: Cribriform, Solid. - Nuclear Grade: Grade III (high). - Necrosis: Present, focal (small foci or single cell necrosis). Lobular Carcinoma In Situ: Not identified. Histologic Type: - Invasive ductal carcinoma (no special type or not otherwise specified). SURGICAL PATHOL Report. Histologic Grade: Nottingham Histologic Score. Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 2: Mitotic Count: Score 2. Overall Grade: Grade 2: scores of 6 or 7. Margins: - Margins uninvolved by invasive carcinoma. -Distance from closest margin: 20 mm (deep). Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 2. Total number of lymph nodes examined (sentinel and nonsentinel): 7. Number of lymph nodes with macrometastases (>0.2 cm): 2. Number of lymph nodes with macrometastases (>0.2 mm to 0.2 cm and/or >200 cells): 0. Size of largest metastatic deposit (if present): 1.5 cm. Extranodal Extension: Indeterminate. Method of Evaluation of Sentinel Lymph Nodes: - H&E, multiple levels. Pathologic Staging: Primary Tumor: pT1c: Tumor >10 mm but <20 mm in greatest dimension. Regional Lymph Nodes: pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. Distant Metastasis: Not applicable. Microcalcifications: PRESENT in DCIS. Anciliary Studies: Estrogen Receptor: - Performed on another specimen I. ); Results: Immunoreactive tumor cells present (1 %). Progesterone Receptor: - Performed on another specimen 1. ; Results: Immunoreactive tumor cells present (1 %). Her2: - Performed on another specimen. i Results: Equivocal (Score 2+). HER2 by FISH: - Performed on another specimen (. Results: AMPLIFIED (HER2 gene copy >6.0 or ratio >2.2). NOTE: IDS-ER, Some PgR immunohistochemical 636=PR, A485=HER2, II-II-EGFR. All immunohistochemical stains are used with formalin or molecular fired. paruffin embedded lissue. Detection Is by Emision Method. The are. antibodies any analyte specific reagents (ASRs) validated by our laboratory. These ASfs are clinically useful indicators that do not require FDA approval. These results clones read are used: by a. pathologist as positive or negative. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s); and (ii) Rendered the diagnosis(es). MD. Intraoperative Consultation. A. Sentinel node #1 count. FS: Metastatic carcinoma seen on touch prep. B. Sentinel node #2 count. FS: Metastatic carcinoma seen on touch prep. : MD. MD. Clinical History: None provided. Operation Performed. SURGICAL PATHOL Report. Right total mastectomy with axillary node dissection and sentinel node biopsy. Pre Operative Diagnosis: Breast ductal carcinoma. Specimen(s) Received: A: Sentinel node #1 count. FS. B: Sentinel node #2 count. , FS. C: Right total mastectomy. Gross Description: A. Received fresh is a segment of tan-brown fibroadipose tissue, 1.8 x 1.5 x 0.7 cm. The specimen is bisected and. submitted in toto in two blocks. B. Received in formalin is a segment of tan-gray soft tissue, 1 x 0.9 x 0.6 cm. The specimen is bisected and submitted in. toto in one block. C. Received in formalin is a 447-gram, 18 x 17.5 x 2 cm right mastectomy specimen. There is an ellipse of pale skin, 14.2 x. 6.1 cm. The nipple/areola complex measures 2.5 x 2 cm. The nipple is retracted. The attached axillary tail measures. 11.5 x 6.5 cm. The specimen is oriented with short stitch superior, two long stitches lateral. The resection margins are. inked black. On serial sectioning, there is a tan-white, indurated, ill-defined lesion with infiltrating borders in the. retroareolar space. It occupies the central compartment and measures 3 x 1.5 x 1.5 cm. It is located 2 cm from the. deep. margin, 7.5 cm from the inferior margin, 5 cm from the superior margin, 7 cm from the medial margin, and 9 cm from the. lateral margin. No additional lesions are identified. Examination of the axillary tail reveais. multiple possible. lymph nodes. Sections are submitted as follows: 1. Nipple. 2. Deep margin (closest). 3-9. Lesion submitted in toto. 10-12. One lymph node per block. 13&14. Three lymph nodes per block.

expanded version (tokens=2017) : 
 Based on the provided pathology report, the following information can be extracted:

1. Histological classification: Invasive ductal carcinoma (no special type or not otherwise specified) with DCIS present.
2. Subtype: Not available.
3. Description of necrosis: Present, focal (small foci or single cell necrosis).
4. Tumor infiltrating lymphocytes: Not mentioned.
5. Histological grade: Nottingham Histologic Score, Grade 2: scores of 6 or 7.
6. Nuclear grade: Score 2.
7. Lymphovascular invasion: Not identified.
8. Calcification: Present in DCIS.
9. Receptor status: ER and PR positive by immunohistochemistry; HER2 amplified by FISH.
10. IHC and ancillary testing results: Equivocal HER2 score 2+ by IHC, amplified HER2 gene copy by FISH; estrogen and progesterone receptor positive.

Additional information:
- Size of largest invasive carcinoma: 1.6 cm in greatest dimension.
- Resection margins are free of tumor, closest margin at 2.0 cm (deep).
- No malignancy seen in five lymph nodes (0/5), metastatic carcinoma present in two sentinel nodes.
- AJCC Staging: pT1c, pN1a, pMn/a.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2179) : 
 Invasive ductal carcinoma (no special type) with DCIS was detected in a 1.6cm mass with focal necrosis, grade 2 histologically. ER and PR were positive by immunohistochemistry; HER2 amplified by FISH. No lymphovascular invasion was identified, and lymph node involvement was observed in two sentinel nodes but not in five examined. Resection margins were tumor-free at the closest point of 2.0 cm (deep). AJCC staging is pT1c, pN1a, pMn/a.

